Business Description
Memphasys Ltd
ISIN : AU000000MEM5
Description
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | -1.41 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -5.38 | |||||
| Beneish M-Score | 8.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year FCF Growth Rate | 20.6 | |||||
| 3-Year Book Growth Rate | -20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.15 | |||||
| 9-Day RSI | 59.77 | |||||
| 14-Day RSI | 61.3 | |||||
| 6-1 Month Momentum % | -28.57 | |||||
| 12-1 Month Momentum % | -64.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.31 | |||||
| Quick Ratio | 0.28 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 916.7 | |||||
| Days Sales Outstanding | 5468.92 | |||||
| Days Payable | 2424.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.5 | |||||
| Shareholder Yield % | -16.38 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 3.33 | |||||
| Operating Margin % | -8731.67 | |||||
| Net Margin % | -7405 | |||||
| FCF Margin % | -6450 | |||||
| ROE % | -63.96 | |||||
| ROA % | -33.12 | |||||
| ROIC % | -31.64 | |||||
| 3-Year ROIIC % | -99.15 | |||||
| ROC (Joel Greenblatt) % | -204.72 | |||||
| ROCE % | -50.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.8 | |||||
| EV-to-EBIT | -4.97 | |||||
| EV-to-EBITDA | -6.01 | |||||
| EV-to-Revenue | 341.18 | |||||
| EV-to-FCF | -5.29 | |||||
| Earnings Yield (Greenblatt) % | -20.12 | |||||
| FCF Yield % | -24.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Memphasys Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.06 | ||
| EPS (TTM) (A$) | -0.004 | ||
| Beta | 0.91 | ||
| Volatility % | 115.31 | ||
| 14-Day RSI | 61.3 | ||
| 14-Day ATR (A$) | 0.000867 | ||
| 20-Day SMA (A$) | 0.0073 | ||
| 12-1 Month Momentum % | -64.29 | ||
| 52-Week Range (A$) | 0.004 - 0.014 | ||
| Shares Outstanding (Mil) | 1,771.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Memphasys Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Memphasys Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Memphasys Ltd Frequently Asked Questions
What is Memphasys Ltd(ASX:MEM)'s stock price today?
The current price of ASX:MEM is A$0.01. The 52 week high of ASX:MEM is A$0.01 and 52 week low is A$0.00.
When is next earnings date of Memphasys Ltd(ASX:MEM)?
The next earnings date of Memphasys Ltd(ASX:MEM) is .
Does Memphasys Ltd(ASX:MEM) pay dividends? If so, how much?
Memphasys Ltd(ASX:MEM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers